第53回日本小児循環器学会総会・学術集会

講演情報

AP Target Symposium

AP Target Symposium 4 (III-APT4)
Optimizing results in staged surgical management of functionally univentricular hearts – Preparation rather than Selection for Fontan –

2017年7月9日(日) 08:30 〜 10:15 第3会場 (1F 展示イベントホール Room 3)

座長:猪飼 秋夫(静岡県立こども病院 心臓血管外科)
座長:Swee Chye Quek (Pediatrics, National University of Singapore, Singapore)

08:30 〜 10:15

[III-APT4-02] Arrhythmia management as a preparation for a Fontan

Heima Sakaguchi (Department of Pediatric Cardiology, National Cerebral and Cardiovascular Center, Osaka, Japan)

In patients with a single ventricular physiology, arrhythmias can be a risk factor for surgical treatment including a bidirectional Glenn (BDG)/total cavopulmonary connection (TCPC) completion. Cases with hypoplastic right or left heart syndrome especially are often complicated with atrial arrhythmias due to a unilateral atrial load continuing from the fetal period. Herein we reviewed 8 cases (12 sessions) who underwent radiofrequency catheter ablation (RFCA) prior to a BDG/TCPC completion in our hospital over the last decade. Two patients were excluded from this study because they did not have an indication for a TCPC completion at that time. Of the 6 patients, underlying congenital heart defects consisted of a pulmonary atresia (PA) with an intact ventricular septum s/p Blalock Taussig (BT) shunt in 2, hypoplastic left heart syndrome (HLHS) s/p Norwood in 2, tricuspid atresia PA s/p BT shunt in 1, and atrio-ventricular discordance and mitral atresia s/p BDG in 1. Among 10 sessions, the median age and body weight at the time of the RFCA were 7 months and 5.3 kg, respectively. The target arrhythmias that were ablated were focal atrial tachycardia (AT) in 4 cases (8 sessions), intra-atrial re-entrant tachycardia in 1, and AVRT in 1. Although 3 out of 6 patients required multiple sessions because of difficulty inducing AT, their arrhythmia substrates were successfully eliminated. After the RFCA, all underwent a BDG/TCPC completion. It is very useful option as a preparation for the Fontan to tenaciously attempt to ablate any atrial arrhythmias prior to the BDG/TCPC.